Data is compiled from public records and verified media reports.
Last Updated: October 27, 2026
Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.
Jochem Gokemeijer, PhD. - Pre-clinical Morten Nielsen, PhD. - The use of HLA class II antigen presentation prediction in the context of Rajanikanth Madabushi, PhD. – Integration of MIDD into Malachi Griffith, PhD. - Bioinformatics and immunogenomics Lora Hamuro, PhD. - Quantitative Richard White, PhD. and Sophie Rhodes, Ph.D - Using Epidemiological and Immunostimulation/Immunodynamic Guangping Gao, PhD. - Vector-related Andrzej Kierzek, PhD. - Quantitative Systems Pharmacology to predicting and managing impact of Peter Marks, MD. PhD. – Welcome Remarks. Brandon Dekosky, PhD. - Exploring Personalization of Human Immune Responses with High-Throughput Immune Receptor Data. Peter Gilbert, PhD. - Learning Immune Correlates of Protection from Vaccine Efficacy Trials. Nirjal Bhattarai, PhD. - mmunogenicity of Chimeric Antigen Receptor T Cells. Aleksander Popel, PhD. – Quantitative Systems Pharmacology: applications to immuno-oncology. QSP Application to COVID-19 Vaccine Clinical Yongqun He, Ph.D. - COVID-19 vaccine machine learning, ontology
Size: 4.25 MB · Format: PDF · Secure Download
Our platform aggregates the most comprehensive and up-to-date insights, ensuring you get relevant details about Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop.
Interest in Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop has surged recently as more people seek reliable resources, related media, and detailed analysis.
You can explore extensive galleries, video summaries, and related content directly on this page.
We regularly update our database with the latest information, media, and analysis related to Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop.
